Literature DB >> 3346742

Clinical significance of isolated scintigraphic sternal lesions in patients with breast cancer.

A H Kwai1, P C Stomper, W D Kaplan.   

Abstract

Isolated scintigraphic sternal lesions are rare. In a retrospective review of the bone scan results of 1,104 patients with breast cancer, 34 individuals (3.1%) presented with this abnormality. Of these foci, 26 (76%) were found to represent metastatic disease. There did not appear to be a relationship with axillary lymph node metastasis, the quadrant involved by primary breast tumor, or selected serum chemistries. These sternal lesions may be associated with regional lymphatic tumor spread rather than hematogenous seeding and therefore could be considered a local recurrence.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3346742

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  10 in total

Review 1.  Internal mammary lymph node metastases in breast cancer: what should radiologists know?

Authors:  Misugi Urano; Fatmaelzahraa Abdelfattah Denewar; Taro Murai; Masaru Mizutani; Masanori Kitase; Kazuya Ohashi; Norio Shiraki; Yuta Shibamoto
Journal:  Jpn J Radiol       Date:  2018-09-07       Impact factor: 2.374

2.  Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement.

Authors:  Kaitlin Christopherson; Xiudong Lei; Carlos Barcenas; Thomas A Buchholz; Naveen Garg; Karen E Hoffman; Henry Mark Kuerer; Elizabeth Mittendorf; George Perkins; Simona F Shaitelman; Grace L Smith; Michael Stauder; Eric A Strom; Welela Tereffe; Wendy A Woodward; Benjamin D Smith
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-03-06       Impact factor: 7.038

Review 3.  Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targets.

Authors:  Nadia Rucci; Patrizia Sanità; Simona Delle Monache; Edoardo Alesse; Adriano Angelucci
Journal:  World J Clin Oncol       Date:  2014-08-10

4.  Solitary metastatic adenocarcinoma of the sternum treated by total sternectomy and chest wall reconstruction using a Gore-Tex patch and myocutaneous flap: a case report.

Authors:  Stavros I Daliakopoulos; Michael N Klimatsidas; Reiner Korfer
Journal:  J Med Case Rep       Date:  2010-03-01

Review 5.  Internal mammary lymph node metastasis in breast cancer patients based on anatomical imaging and functional imaging.

Authors:  Wei Wang; Pengfei Qiu; Jianbin Li
Journal:  Breast Cancer       Date:  2022-06-24       Impact factor: 3.307

6.  Simultaneous chest wall reconstruction after sternectomy and modified radical mastectomy in locally advanced breast cancer with solitary sternal metastasis.

Authors:  Hyun Jong Kang; Song Am Lee; Kyoung Sik Park; Jung-Hyun Yang; Young Bum Yoo
Journal:  J Breast Cancer       Date:  2012-12-31       Impact factor: 3.588

7.  Sternal resection and reconstruction after malignant tumours.

Authors:  J M Galbis Caravajal; L Yeste Sánchez; C A Fuster Diana; R Guijarro Jorge; P Fernández Ortiz; P J Deaville
Journal:  Clin Transl Oncol       Date:  2009-02       Impact factor: 3.405

Review 8.  Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy.

Authors:  Caterina Fontanella; Valentina Fanotto; Karim Rihawi; Giuseppe Aprile; Fabio Puglisi
Journal:  Clin Exp Metastasis       Date:  2015-09-07       Impact factor: 5.150

Review 9.  Society of Skeletal Radiology- white paper. Guidelines for the diagnostic management of incidental solitary bone lesions on CT and MRI in adults: bone reporting and data system (Bone-RADS).

Authors:  Connie Y Chang; Hillary W Garner; Shivani Ahlawat; Behrang Amini; Matthew D Bucknor; Jonathan A Flug; Iman Khodarahmi; Michael E Mulligan; Jeffrey J Peterson; Geoffrey M Riley; Mohammad Samim; Santiago A Lozano-Calderon; Jim S Wu
Journal:  Skeletal Radiol       Date:  2022-03-28       Impact factor: 2.128

10.  Sternal resection for recurrent breast cancer: a cautionary tale.

Authors:  L Lee; A Keller; M Clemons
Journal:  Curr Oncol       Date:  2008-08       Impact factor: 3.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.